Transdermal penetration of vasoconstrictors - Present understanding and assessment of the human epidermal flux and retention of free bases and ion-pairs

Pharmaceutical Research

Volumn 20, Issue 2, 2003, Pages 270-274

  Cross, Sheree E ^a   Thompson, Melanie J ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Epidermal retention; Percutaneous absorption; Transdermal; Vasoconstrictor

Indexed keywords

BASE; EPHEDRINE; NAPHAZOLINE; OXYMETAZOLINE; PARAFFIN; PHENYLEPHRINE; PROPYLENE GLYCOL; TETRYZOLINE; VASOCONSTRICTOR AGENT; XYLOMETAZOLINE;

ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ION PAIR EXTRACTION; MELTING POINT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ADULT; EPIDERMIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; IONS; VASOCONSTRICTOR AGENTS;

EID: 0037331307     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022235507186     Document Type: Article

References (27)

1. M. S. Roberts, S. E. Cross, and M. A. Pellett. Skin Transport in Dermatological and Transdermal Formulations ed KA Walters Marcel Dekker, New York (2002) pp 89-195.
2. W. J. Pugh, M. S. Roberts, and J. Hadgraft. Epidermal permeability-penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 138:149-167 (1996).
3. P. Singh and M. S. Roberts. Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J. Pharm. Sci. 83:783-791 (1994).
4. C. S. Canepa, S. H. Miller, D. C. Buck, R. J. Demuth, and M. Miller. Effects of phenylephrine on tissue gas tension, bleeding, infection and lidocaine absorption. Plast. Reconstr. Surg. 81:554-560 (1988).
5. J. E. Riviere, B: Sage, and P. L. Williams. The effects of vasoactive drugs on transdermal lidocaine iontophoresis. J. Pharm. Sci. 80:615-620 (1991).
6. J. E. Riviere, N. A. Monterio-Riviere, and A. O. Inman. Determination of lidocaine concentrations in skin after transdermal iontophoresis: Effects of vasoactive drugs. Pharm. Res. 9:211-214 (1992).
7. T. R. P. Ford, M. A. Seare, and F. McDonald. Action of adrenaline on the effect of dental local anaesthetic solutions. Endodon. Dent. Traumatol. 91:31-35 (1993).
8. Y. W. Chien and S.-F. Chang. Intranasal drug delivery for systemic medications. CRC Crit. Rev. Drug Carrier Syst. 4:66-194 (1987).
9. G. M. Irwin, H. B. Kostenbauder, L. W. Dittert, R. Staples, A. Misher, and J. V. Swintosky. Enhancement of gastrointestinal absorption of a quaternarry ammonium compound by trichloroacetate. J. Pharm. Sci. 58:313-315 (1969).
10. D. J. W. Grant and T. Higuchi. Ion pairs and solubility behaviour. In: W. H. Saunders (ed.) Solubility Behaviour of Organic Compounds, Vol XXI of the Techniques of Chemistry Series, Wiley, New York, 1990 pp. 399-439.
11. S. Matschiner, R. Neubert, and W. Wohlrab. The use of ionpairing to facilitate percutaneous penetration of drugs. In: E. W. Smith, and H. I. Maibach (eds.), Percutaneous Penetration Enhancers. CRC Press, New York, 1995 pp. 407-417.
12. M. Kadono, K. Kubo, H. Miyazaki, N. Tojyo, S. Nakagawa, K. Miyashita, T. Imanishi, J. H. Rytting, and T. Mayumi. Enhanced in vitro percutaneous penetration of saliclyate by ion pair formation with alkylamines. Biol. Pharm. Bull. 21:599-603 (1998).
13. S. A. Megwa, S. E. Cross, H. A. E. Benson, and M. S. Roberts. Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. J. Pharm. Pharmacol. 52:919-928 (2000).
14. S. A. Megwa, H. A. E. Benson, and M. S. Roberts. Percutaneous absorption of SAs from some commercially available topical products containing methylsalicylate or salicylic acid salts in rats. J. Pharm. Pharmacol. 47:891-896 (1995).
15. K. A. Walters and J. Hadgraft. Pharmaceutical skin penetration enhancement. Drugs in the Pharmaceutical Sciences, Vol. 59. Marcel Dekker, New York, 1993.
16. M. Bende. The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta. Otolaryngol. (Stockh.) 96:523-527 (1983).
17. E. Lunell, L. Molander, and M. Andersson. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant. Eur. J. Clin. Pharmacol. 48:71-75 (1995).
18. M. C. Koss. Characterization of adrenoceptor subtypes in cat cutaneous vasculature. J. Pharmacol. Exp. Ther. 254:221-227 (1990).
19. Y. Kaplun-Frischoff and E. Touitou. Testosterone skin permeation enhancement by menthol through the formation of a tectic with drug and interaction with skin lipids. J. Pharm. Sci. 86:1394-1399 (1997).
20. W. Stott, A. C. Williams, and B. W. Barry. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Control. Release 50:297-308 (1997).
21. D. B. Larsen, H. Parshad, K. Fredholt, and C. Larsen. Characteristics of drug substances in oily solutions. Drug release rate, partitioning and solubility. Int. J. Pharm. 232:107-117 (2002).
22. M.-W. Hu and L. E. Matheson. The development of a predictive method for the estimation of flux through polydimethylsiloxane membranes. III. Application to a series of substituted pyridines. Pharm. Res. 10:732-736 (1993).
23. T. Kai, T. Isami, K. Kobota, Y. Kurosaki, T. Nakayama, and T. Kimura. Keratinised epithelial transport of beta-blocking agents. I. Relationship between physicochemical properties of drugs and the flux across rat skin and hamster skin cheek pouch. Chem. Pharm. Bull. 40:2498-2504 (1992).
24. T. Izumoto, A. Aioi, S. Uneoyama, K. Kuriyama, and M. Azuma. Relationship between transference of a drug from a transdermal patch and the physicochemical properties. Chem. Pharm. Bull. 40:456-468 (1992).
25. B. Ghosh and L. H. Reddy. Effect of physicochemical parameters on skin permeability of antihypertensive. Indian J. Exp. Biol. 39:710-714 (2001).
26. A. Pardo, Y. Shiri, and S. Cohen. Kinetics of transdermal penetration of an organic ion pair: physostigmine salicylate. J. Pharm. Sci. 81:990-995 (1992).
27. J. C. Smith and W. J. Irwin. Ionization and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin. Int. J. Pharm. 210:69-82 (2000).